Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anidulafungin Dose-Ranging Study in Invasive Candidiasis
NCT00037219Phase 2Completed
- Sponsor
- Pfizer
- Start
- Aug 2001
- Modality
- Small Molecules, Cyclic Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of anidulafungin in invasive candidiasis, candidemia, sponsored by Pfizer. Started Aug 2001; status: completed.
02
Drugs
anidulafungin
03
Conditions
invasive candidiasiscandidemia
Beyond the preview
Go deeper on NCT00037219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00037219.